Protia Inc. (KOSDAQ:303360)
South Korea · Delayed Price · Currency is KRW 4,955.00
-15.00 (-0.30%)
At close: Aug 11, 2026
Protia Market Cap
Protia has a market cap or net worth of 64.01 billion as of August 12, 2026. Its market cap has increased by 27.30% in one year.
Market Cap
64.01B
Enterprise Value
51.06B
Revenue
16.25B
Ranking
n/a
PE Ratio
15.94
Stock Price
4,955.00
ChartMarket Cap Chart
Since December 19, 2018, Protia's market cap has decreased from 78.41B to 64.01B, a decrease of -18.36%. That is a compound annual growth rate of -2.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 63.82B | -20.58% |
| Dec 30, 2025 | 80.35B | 127.74% |
| Dec 30, 2024 | 35.28B | -16.19% |
| Dec 28, 2023 | 42.10B | -45.57% |
| Dec 29, 2022 | 77.35B | 24.57% |
| Dec 30, 2021 | 62.09B | -38.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 270.19B |
| 3billion | 200.80B |
| GENINUS | 93.75B |
| Cytogen | 84.78B |
| Inventera | 66.23B |
| GC Medical Science | 63.70B |
| HLB Panagene | 52.77B |
| Seoulin Bioscience | 41.32B |